BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Amylyx Pharmaceuticals Inc. (AMLX)

1 post
Biogen Expands Immunology Portfolio with Strategic Acquisition

Biotech NewsAmylyx (AMLX) Reports $234.4M in Cash, Secures Financial Stability Through 2026

  • BioTech Health X
  • December 23, 2024
Amylyx Pharmaceuticals Inc. (AMLX) is a cutting-edge biotechnology company dedicated to developing innovative therapies for neurodegenerative and metabolic…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Protagonist Therapeutics (PTGX)Exceeds Revenue Estimates in Q3 2024
  • Madrigal Pharmaceuticals (MDGL): A Financial Powerhouse With $1.0 Billion Cash Position in 2024
  • Kamada (KMDA) Reports Strong Q3 2024 Financial Results with $41.7M in Revenue
  • Gossamer Bio (GOSS) Reports Strong Q3 2024 Financial Results
  • Lakeside (LSH) Partners with Huiyu Pharmaceutical to Expand Global Oncology Drug Distribution
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • January 16, 2025
    Protagonist Therapeutics (PTGX)Exceeds Revenue Estimates in Q3 2024
    • January 16, 2025
    Madrigal Pharmaceuticals (MDGL): A Financial Powerhouse With $1.0 Billion Cash Position in 2024
    • January 14, 2025
    Kamada (KMDA) Reports Strong Q3 2024 Financial Results with $41.7M in Revenue
    • January 14, 2025
    Gossamer Bio (GOSS) Reports Strong Q3 2024 Financial Results
    • January 7, 2025
    Lakeside (LSH) Partners with Huiyu Pharmaceutical to Expand Global Oncology Drug Distribution
Recent Posts
  • Sanara MedTech (SMTI) Achieves Record $21.7M Revenue in Q3 2024
    • January 2, 2025
  • Aldeyra (ALDX) Reports $15.1M Q3 2024 Loss Amid R&D Investments
    • January 2, 2025
  • Galectin (GALT) Reports Improved Financial Performance in Q3 2024
    • December 31, 2024
Categories
  • BioTech CEO Interviews (5)
  • Biotech Info (1)
  • Biotech News (118)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top